Big Pharma tops our latest roundup of deals worth $1 billion or more, with AbbVie Inc. agreeing to purchase cancer-drug maker Pharmacyclics Inc. for $21 billion. In another deal surpassing the $10 billion mark, NXP Semiconductors N.V. will acquire Freescale Semiconductor Ltd. for $11.8 billion. Rounding out the top three is a Citigroup subsidiary that will sell subprime lender OneMain Financial Holdings Inc. to Springleaf Holdings Inc. for $4.25 billion.
Skadden, Arps, Slate, Meagher & Flom advised on the most number of billion-dollar deals this week, with four, while Wachtell, Lipton, Rosen & Katz topped the list by transaction value.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
